Tomalka AG - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

In vitro Evidence That Combination Therapy With CD16-Bearing NK-92 Cells and FDA-Approved Alefacept Can Selectively Target the Latent HIV Reservoir in CD4+ CD2hi Memory T Cells.

Tomalka AG, Resto-Garay I, Campbell KS, Popkin DL. Tomalka AG, et al. Front Immunol. 2018 Nov 5;9:2552. doi: 10.3389/fimmu.2018.02552. eCollection 2018. Front Immunol. 2018. PMID: 30455699 Free PMC article.

Dimerization of the Pseudomonas aeruginosa translocator chaperone PcrH is required for stability, not function.

Tomalka AG, Zmina SE, Stopford CM, Rietsch A. Tomalka AG, et al. J Bacteriol. 2013 Nov;195(21):4836-43. doi: 10.1128/JB.00335-13. Epub 2013 Aug 23. J Bacteriol. 2013. PMID: 23974025 Free PMC article.

A translocator-specific export signal establishes the translocator-effector secretion hierarchy that is important for type III secretion system function.

Tomalka AG, Stopford CM, Lee PC, Rietsch A. Tomalka AG, et al. Mol Microbiol. 2012 Dec;86(6):1464-81. doi: 10.1111/mmi.12069. Epub 2012 Nov 5. Mol Microbiol. 2012. PMID: 23121689 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters